An increase in the serum level of TNF-α after initiation of treatment with etanercept was previously described in adult patients with TNF receptor-associated periodic syndrome, multiple myeloma, orthoclone (OKT)-associated syndrome, and metastatic breast cancer [15–18]. Here, TNF is linked to Down syndrome.